This content originally appeared on Reuters and was authored by Reuters
This content originally appeared on Reuters and was authored by Reuters
Print
Share
Comment
Cite
Upload
Translate
Updates
There are no updates yet.
Click the Upload button above to add an update.
APA
MLA
Reuters | Sciencx (2025-09-11T04:16:58+00:00) No pain, no gain: Ozempic’s quest for market share. Retrieved from https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/
" » No pain, no gain: Ozempic’s quest for market share." Reuters | Sciencx - Thursday September 11, 2025, https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/
HARVARDReuters | Sciencx Thursday September 11, 2025 » No pain, no gain: Ozempic’s quest for market share., viewed ,<https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/>
VANCOUVERReuters | Sciencx - » No pain, no gain: Ozempic’s quest for market share. [Internet]. [Accessed ]. Available from: https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/
CHICAGO" » No pain, no gain: Ozempic’s quest for market share." Reuters | Sciencx - Accessed . https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/
IEEE" » No pain, no gain: Ozempic’s quest for market share." Reuters | Sciencx [Online]. Available: https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/. [Accessed: ]
rf:citation » No pain, no gain: Ozempic’s quest for market share | Reuters | Sciencx | https://www.scien.cx/2025/09/11/no-pain-no-gain-ozempics-quest-for-market-share/ |
Please log in to upload a file.
There are no updates yet.
Click the Upload button above to add an update.